This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Data pager
Data pager
12
 Item 1 to 99 of 103
of 2 
Show all 103
Data pager
Data pager
12
 Item 1 to 99 of 103
of 2 
Show all 103
Sunday, April 07 | 4:00PM - 8:00PM
Arrival and Registration
Room: Colorado Ballroom Foyer


Sunday, April 07 | 6:00PM - 8:00PM
Welcome Mixer
Room: Colorado Ballroom Foyer
No registration fees are used to fund alcohol served at this function.

Monday, April 08 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Monday, April 08 | 8:00AM - 9:30AM
Welcome and Keynote Session
Room: Colorado Ballroom

Speaker 1 of 4
* Christian Klein, Roche, Switzerland

Monday, April 08 | 8:00AM - 9:30AM
Welcome and Keynote Session
Room: Colorado Ballroom

Speaker 2 of 4
George D. Yancopoulos, Regeneron Pharmaceuticals, Inc., USA
Target Identification and Developing Antibodies for Clinical Application

Monday, April 08 | 8:00AM - 9:30AM
Welcome and Keynote Session
Room: Colorado Ballroom

Speaker 3 of 4
Jennifer R. Cochran, Stanford University, USA
Emerging Strategies for Developing Next-Generation Protein Therapeutics

Monday, April 08 | 8:00AM - 9:30AM
Welcome and Keynote Session
Room: Colorado Ballroom


Coffee Break

Monday, April 08 | 9:50AM - 11:45AM
Mechanisms of Action for Depleting Antibodies
Room: Colorado Ballroom

Speaker 1 of 6
* Janine Schuurman, Genmab B.V., Netherlands

Monday, April 08 | 9:50AM - 11:45AM
Mechanisms of Action for Depleting Antibodies
Room: Colorado Ballroom

Speaker 2 of 6
Mark S. Cragg, University of Southampton, UK
Targeting B Cells with Antibodies: From Oncology to Autoimmunity

Monday, April 08 | 9:50AM - 11:45AM
Mechanisms of Action for Depleting Antibodies
Room: Colorado Ballroom

Speaker 3 of 6
Falk Nimmerjahn, Universitätsklinikum Erlangen, Germany
The Where, When, and How: Organ Specific Pathways of Cytotoxic IgG Activity

Monday, April 08 | 9:50AM - 11:45AM
Mechanisms of Action for Depleting Antibodies
Room: Colorado Ballroom

Speaker 4 of 6
Annalee W. Nguyen, University of Texas at Austin, USA
Short Talk: Antibodies Engineered for Enhanced Binding and Effector Activity in the Low pH of the Tumor Microenvironment

Monday, April 08 | 9:50AM - 11:45AM
Mechanisms of Action for Depleting Antibodies
Room: Colorado Ballroom

Speaker 5 of 6
Polina Weitzenfeld, Rockefeller University, USA
Short Talk: Antibody Targeting of Carbohydrate-Associated Tumor Antigens Reveals Novel Effector Cell Pathways for Tumor Clearance

Monday, April 08 | 9:50AM - 11:45AM
Mechanisms of Action for Depleting Antibodies
Room: Colorado Ballroom

Speaker 6 of 6
Michael M. Schmidt, Compass Therapeutics, USA
Short Talk: Novel Class of NK Engagers Targeting NKp30 Selected from Unbiased Screen of Common Light Chain-Based Bispecific Antibodies

Monday, April 08 | 11:45AM - 5:00PM
On Own for Lunch


Monday, April 08 | 11:45AM - 1:00PM
Poster Setup
Room: Breckenridge Ballroom


Monday, April 08 | 1:00PM - 10:00PM
Poster Viewing
Room: Breckenridge Ballroom


Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 1 of 9
* Christian Klein, Roche, Switzerland

Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 2 of 9
Starlynn Clarke, TeneoBio Inc., USA
A Novel CD3xPSMA Bispecific Antibody for Efficient T-Cell Mediated Killing of Prostate Tumor Cells with Minimal Cytokine Release

Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 3 of 9
Lynn A. Kamen, Genentech, Inc., USA
A Novel Cell-Based Assay for Predicting Bispecific Antibody Activity and its PK-PD Effects

Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 4 of 9
Jason Lajoie, Compass Therapeutics, USA
A Versatile Platform for Efficient Affinity Optimization of Common Light Chain Bispecific Antibodies

Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 5 of 9
Ahlam Qerqez, University of Texas at Austin, USA
Human Cytomegalovirus-Specific T Cell Receptor Engineered for High Affinity and Soluble Expression using Mammalian Cell Display

Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 6 of 9
Diana Darowski, Roche Gylcart AG, Switzerland
Antibodies as Drugs: P329G LALA Mutated Antibodies Enable Precise Redirection of Anti-P329G-Based Chimeric Antigen Receptor T Cells (P329G-CAR-T cells)

Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 7 of 9
Koen Wagner, AIMM Therapeutics, Netherlands
AT1413 T-Cell Engager Activity Is Determined by T-Cell Engager Format Valency

Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 8 of 9
Phillip Liu, Sound Biologics, USA
Development of MabPair Technology, a Novel Platform for Producing Bifunctional Antibody Products

Monday, April 08 | 2:30PM - 4:30PM
Workshop 1: Engineering (Bispecific) Antibodies
Room: Colorado Ballroom

Speaker 9 of 9
Brandy R. White, California State University, Fresno, USA
Humanization of a MUC16 Specific Monoclonal Antibody for the Treatment of Pancreatic Cancer

Monday, April 08 | 4:30PM - 5:00PM
Coffee Available
Room: Colorado Ballroom Foyer


Monday, April 08 | 5:00PM - 7:00PM
Antibody Engineering
Room: Colorado Ballroom

Speaker 1 of 6
* James A. Ernst, Genentech, Inc., USA

Monday, April 08 | 5:00PM - 7:00PM
Antibody Engineering
Room: Colorado Ballroom

Speaker 2 of 6
Janine Schuurman, Genmab B.V., Netherlands
Engineering Non-Classical Antibody Formats Inspired by Nature

Monday, April 08 | 5:00PM - 7:00PM
Antibody Engineering
Room: Colorado Ballroom

Speaker 3 of 6
Feng Wang, Chinese Academy of Sciences, China
A Tumor Targeted Immune Checkpoint Blocker

Monday, April 08 | 5:00PM - 7:00PM
Antibody Engineering
Room: Colorado Ballroom

Speaker 4 of 6
Germaine Fuh, 23andMe, Inc., USA
Engineering Antibody Specificity and Stability Using Deep Sequencing

Monday, April 08 | 5:00PM - 7:00PM
Antibody Engineering
Room: Colorado Ballroom

Speaker 5 of 6
Aliza Borenstein-Katz, Weizmann Institute, Israel
Short Talk: Optimization of Antibody Anti Pancreatic Cancer Marker

Monday, April 08 | 5:00PM - 7:00PM
Antibody Engineering
Room: Colorado Ballroom

Speaker 6 of 6
Chia Yin Lee, Singapore Immunology Network, Singapore
Short Talk: Engineering the Fragment Crystallizable (Fc) Region of Antibody for Dendritic Cell-Based Vaccine

Monday, April 08 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Breckenridge Ballroom
No registration fees are used to fund alcohol served at this function.

Monday, April 08 | 7:30PM - 10:00PM
Poster Session 1
Room: Breckenridge Ballroom


Tuesday, April 09 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom

Speaker 1 of 9
* Andreas G. Plückthun, University of Zürich, Switzerland

Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom

Speaker 2 of 9
Nai-Kong V. Cheung, Memorial Sloan-Kettering Cancer Center, USA
Cancer Immunotherapy and Radioimmunotherapy with Bispecific Antibodies

Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom

Speaker 3 of 9
Christian Klein, Roche, Switzerland
Engineering Bispecific Antibodies for Combination Cancer Immunotherapy

Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom


Coffee Break

Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom

Speaker 5 of 9
John R. Desjarlais, Xencor, Inc., USA
Bispecific Antibodies for T Cell Recruitment and T Cell Activation

Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom

Speaker 6 of 9
Yvonne Y. Chen, University of California, Los Angeles, USA
Engineering Next-Generation Chimeric Antigen Receptors

Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom

Speaker 7 of 9
Udaya S Rangaswamy, Teneobio, USA
Short Talk: A Novel T-Cell Bispecific Antibody Platform for Efficient T Cell-Mediated Killing of Tumor Cells with Minimal Cytokine Release

Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom

Speaker 8 of 9
Lina Bartels, AIMM Therapeutics & Amsterdam University Medical Center, Netherlands
Short Talk: A T-Cell Engager Based on a Unique AML Patient-Derived Anti-CD43 Antibody Has a Strong Anti-AML Activity in vivo without Affecting Normal Hematopoietic Cells

Tuesday, April 09 | 8:00AM - 11:15AM
Bispecific and Engineered Antibodies for Cancer Immunotherap
y

Room: Colorado Ballroom

Speaker 9 of 9
Chad May, Maverick Therapeutics, USA
Short Talk: COBRA: A Novel Conditionally Active Bispecific Antibody that Regresses Established Solid Tumors in Mice

Tuesday, April 09 | 11:15AM - 5:00PM
On Own for Lunch


Tuesday, April 09 | 11:15AM - 1:00PM
Poster Setup
Room: Breckenridge Ballroom


Tuesday, April 09 | 1:00PM - 10:00PM
Poster Viewing
Room: Breckenridge Ballroom


Tuesday, April 09 | 4:30PM - 5:00PM
Coffee Available
Room: Colorado Ballroom Foyer


Tuesday, April 09 | 5:00PM - 7:00PM
Antibodies for Infectious Diseases
Room: Colorado Ballroom

Speaker 1 of 6
* Christoph Rader, The Scripps Research Institute, USA

Tuesday, April 09 | 5:00PM - 7:00PM
Antibodies for Infectious Diseases
Room: Colorado Ballroom

Speaker 2 of 6
David D. Ho, Aaron Diamond AIDS Research Center (ADARC), Columbia University Medical Center, USA
A Bispecific Antibody, 10E8.4/iMab, for HIV Therapy and Prevention

Tuesday, April 09 | 5:00PM - 7:00PM
Antibodies for Infectious Diseases
Room: Colorado Ballroom

Speaker 3 of 6
JoAnn A. Suzich, AstraZeneca, USA
Antibodies for the Prevention and Treatment of Viral Infections

Tuesday, April 09 | 5:00PM - 7:00PM
Antibodies for Infectious Diseases
Room: Colorado Ballroom

Speaker 4 of 6
Kartik Chandran, Albert Einstein College of Medicine, USA
Development of Engineered and Natural Antibodies as Anti-Ebola Therapeutics

Tuesday, April 09 | 5:00PM - 7:00PM
Antibodies for Infectious Diseases
Room: Colorado Ballroom

Speaker 5 of 6
Sisi Shan, Tsinghua University, China
Short Talk: Broad and Potent Bispecific Neutralizing Antibodies against Filovirus

Tuesday, April 09 | 5:00PM - 7:00PM
Antibodies for Infectious Diseases
Room: Colorado Ballroom

Speaker 6 of 6
Anna Zumsteg, Regeneron Pharmaceuticals, USA
Short Talk: Staphylococcus Aureus Specific Monoclonal Antibodies that Escape Binding to Protein A Protect against Invasive
Disease


Tuesday, April 09 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Breckenridge Ballroom
No registration fees are used to fund alcohol served at this function.

Tuesday, April 09 | 7:30PM - 10:00PM
Poster Session 2
Room: Breckenridge Ballroom


Wednesday, April 10 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom

Speaker 1 of 9
* Germaine Fuh, 23andMe, Inc., USA

Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom

Speaker 2 of 9
Ronit Mazor, MedImmune, USA
Immunogenicity of Recombinant Immunotoxins and Approaches to Mitigate It

Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom

Speaker 3 of 9
Kerry Culm-Merdek, ImmunoGen, USA
Optimizing the Activity of Antibody Drug Conjugates

Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom


Coffee Break

Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom

Speaker 5 of 9
John M. Lambert, USA
Site-Specific Conjugation in ADC Design: Panacea or Hype? Lessons from a Case Study with a Maytansinoid Conjugate

Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom

Speaker 6 of 9
W. Michael Kavanaugh, Cytomx Therapeutics, USA
Probody Therapeutics: Antibody Pro-drugs Designed for Safer and More Effective Cancer Therapies

Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom

Speaker 7 of 9
Armine Matevossian, Novartis Institutes for BioMedical Research, USA
Short Talk: Comprehensive Profiling of the Immune-Modulatory Properties of a Cytotoxic ADC Reveals Unique Contributions
by the Antibody Component of the Drug


Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom

Speaker 8 of 9
Bradley Pearse, Magenta Therapeutics, USA
Short Talk: Antibody Drug Conjugates as Targeted Conditioning Agents for Bone Marrow Transplant Patients

Wednesday, April 10 | 8:00AM - 11:15AM
Antibody Drug Conjugates
Room: Colorado Ballroom

Speaker 9 of 9
Brian H. Santich, Memorial Sloan Kettering Cancer Center, USA
Short Talk: Self-Assembling and Disssembling (SADA) Bispecific Antibodies (BsAb) for 2-Step Pretargeted RadioImmunotherapy (PRIT)

Wednesday, April 10 | 11:15AM - 5:00PM
On Own for Lunch


Wednesday, April 10 | 4:30PM - 5:00PM
Coffee Available
Room: Colorado Ballroom Foyer


Wednesday, April 10 | 5:00PM - 7:00PM
Delivering Antibodies into the Brain
Room: Colorado Ballroom

Speaker 1 of 6
* Jennifer R. Cochran, Stanford University, USA

Wednesday, April 10 | 5:00PM - 7:00PM
Delivering Antibodies into the Brain
Room: Colorado Ballroom

Speaker 2 of 6
Joy Yu Zuchero, Denali Therapeutics Inc, USA
CNS Delivery of Therapeutic Proteins using a Novel Fc Fragment Blood-Brain Barrier Transport Vehicle Approach


Wednesday, April 10 | 5:00PM - 7:00PM
Delivering Antibodies into the Brain
Room: Colorado Ballroom

Speaker 3 of 6
Per-Ola Freskgard, Roche Innovation Center Basel, Switzerland
Crossing the Blood-Brain Barrier with Antibodies to Access Brain Targets

Wednesday, April 10 | 5:00PM - 7:00PM
Delivering Antibodies into the Brain
Room: Colorado Ballroom

Speaker 4 of 6
Allan Jensen, Lundbeck, Denmark
Antibody-Based Therapies for Neurodegenerative Diseases

Wednesday, April 10 | 5:00PM - 7:00PM
Delivering Antibodies into the Brain
Room: Colorado Ballroom

Speaker 5 of 6
Mathieu Oosterlaken, Institut de Génomique Fonctionelle, France
Short Talk: Engineering Pharmacology Active Nanobodies to Target mGlu2 Receptor in the Brain

Wednesday, April 10 | 5:00PM - 7:00PM
Delivering Antibodies into the Brain
Room: Colorado Ballroom

Speaker 6 of 6
Chiara Figazzolo, University of Cambridge, UK
Short Talk: Rational Design and Systematic Optimization of Antibodies against the Aggregation of the Aß42 Peptide

Wednesday, April 10 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Breckenridge Ballroom
No registration fees are used to fund alcohol served at this function.

Thursday, April 11 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Thursday, April 11 | 8:00AM - 11:00AM
Bispecific Antibodies and Antibody Like Molecules
Room: Colorado Ballroom

Speaker 1 of 8
* Christian Klein, Roche, Switzerland

Thursday, April 11 | 8:00AM - 11:00AM
Bispecific Antibodies and Antibody Like Molecules
Room: Colorado Ballroom

Speaker 2 of 8
Christoph Rader, The Scripps Research Institute, USA
Chemically Programmed Bispecific Antibodies

Thursday, April 11 | 8:00AM - 11:00AM
Bispecific Antibodies and Antibody Like Molecules
Room: Colorado Ballroom

Speaker 3 of 8
James A. Ernst, Genentech, Inc., USA
A Bispecific Antibody Mimetic of FGF21 for the Treatment of Metabolic Disease and NASH

Thursday, April 11 | 8:00AM - 11:00AM
Bispecific Antibodies and Antibody Like Molecules
Room: Colorado Ballroom


Coffee Break

Thursday, April 11 | 8:00AM - 11:00AM
Bispecific Antibodies and Antibody Like Molecules
Room: Colorado Ballroom

Speaker 5 of 8
Andreas G. Plückthun, University of Zürich, Switzerland
Engineering DARPins for Delivery into Cells

Thursday, April 11 | 8:00AM - 11:00AM
Bispecific Antibodies and Antibody Like Molecules
Room: Colorado Ballroom

Speaker 6 of 8
Krzysztof Masternak, NovImmune SA, Switzerland
Bispecific CD47 Antibodies for Treatment of Cancer

Thursday, April 11 | 8:00AM - 11:00AM
Bispecific Antibodies and Antibody Like Molecules
Room: Colorado Ballroom

Speaker 7 of 8
Peter J. Hudson, Avipep Pty Ltd, Australia
Short Talk: Engineered Antibody Fragments Precisely Loaded with Diagnostic and Therapeutic Payloads with First-in-Man Biodistribution in Cancer Metastases

Thursday, April 11 | 8:00AM - 11:00AM
Bispecific Antibodies and Antibody Like Molecules
Room: Colorado Ballroom

Speaker 8 of 8
Leandrew A. Dailey, Albert Einstein College of Medicine, USA
Short Talk: Engineering Next-Generation Bispecific Antibodies against Filoviruses

Thursday, April 11 | 11:00AM - 5:00PM
On Own for Lunch


Thursday, April 11 | 2:30PM - 4:30PM
Workshop 2: Antibodies for Immunological Applications
Room: Colorado Ballroom

Speaker 1 of 7
* Mark S. Cragg, University of Southampton, UK

Thursday, April 11 | 2:30PM - 4:30PM
Workshop 2: Antibodies for Immunological Applications
Room: Colorado Ballroom

Speaker 2 of 7
Nicole Piché-Nicholas, Pfizer, USA
Changes in Complementarity-Determining Regions Significantly Alter IgG Binding to the Neonatal Fc Receptor (FcRn) and Pharmacokinetics

Thursday, April 11 | 2:30PM - 4:30PM
Workshop 2: Antibodies for Immunological Applications
Room: Colorado Ballroom

Speaker 3 of 7
Trevor RF Smith, Inovio, USA
Active Immunoprophylaxis Employing DNA-Encoded Monoclonal Antibodies (dMAbs™)

Thursday, April 11 | 2:30PM - 4:30PM
Workshop 2: Antibodies for Immunological Applications
Room: Colorado Ballroom

Speaker 4 of 7
Olivia Vergnolle, Albert Einstein College of Medicine, USA
Dengue Virus Glycoprotein E DIII Epitope Engineering for Broadly Neutralizing Antibodies Enhancement

Thursday, April 11 | 2:30PM - 4:30PM
Workshop 2: Antibodies for Immunological Applications
Room: Colorado Ballroom

Speaker 5 of 7
Masahiro Yasunaga, National Cancer Center, Japan
Development of Next-Generation Antibody Therapeutics against Cancer and Autoimmune Disease Utilizing DDS and Molecular Imaging

Thursday, April 11 | 2:30PM - 4:30PM
Workshop 2: Antibodies for Immunological Applications
Room: Colorado Ballroom

Speaker 6 of 7
Henry Wilson, The Scripps Research Institute, USA
A Sortase A Programmable Phage Display Format for Improved Panning of Fab Antibody Libraries

Thursday, April 11 | 2:30PM - 4:30PM
Workshop 2: Antibodies for Immunological Applications
Room: Colorado Ballroom

Speaker 7 of 7
Gregory Mann, École Polytechnique Fédérale de Lausanne, Switzerland
Using Monobodies to Target Cytoplasmic Oncoproteins

Thursday, April 11 | 4:30PM - 5:00PM
Coffee Available
Room: Colorado Ballroom Foyer


Thursday, April 11 | 5:00PM - 6:45PM
Beyond Checkpoint Blockade: Novel Approaches for Immunothera
py

Room: Colorado Ballroom

Speaker 1 of 5
* Mark S. Cragg, University of Southampton, UK

Thursday, April 11 | 5:00PM - 6:45PM
Beyond Checkpoint Blockade: Novel Approaches for Immunothera
py

Room: Colorado Ballroom

Speaker 2 of 5
Mikael C. I. Karlsson, Karolinska Institutet, Sweden
Anti-Marco Antibodies in Tumor Immunotherapy

Thursday, April 11 | 5:00PM - 6:45PM
Beyond Checkpoint Blockade: Novel Approaches for Immunothera
py

Room: Colorado Ballroom

Speaker 3 of 5
Sean Hua Lim, University of Southampton, UK
Optimizing Anti-Tumor Immunity through Manipulation of the Innate-Adaptive Interface using CD27 Agonists

Thursday, April 11 | 5:00PM - 6:45PM
Beyond Checkpoint Blockade: Novel Approaches for Immunothera
py

Room: Colorado Ballroom

Speaker 4 of 5
Sapna Yadavilli, GlaxoSmithKline, USA
GSK 3359609 a Non-T Cell Depleting IgG4 Anti-ICOS Antibody

Thursday, April 11 | 5:00PM - 6:45PM
Beyond Checkpoint Blockade: Novel Approaches for Immunothera
py

Room: Colorado Ballroom

Speaker 5 of 5
Wen Jie Chin, Agency for Science, Technology and Research, Singapore
Short Talk: Engineering Antibodies to Engage TRIM21 Improves Antigen Cross-Presentation in Human Monocyte-Derived Dendritic Cells

Thursday, April 11 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Colorado Ballroom


No content found

No content found

No content found